Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Costine BA, Oberlander JG, Davis MC, Penatti CA, Porter DM, Leaton RN, Henderson LP.

Psychoneuroendocrinology. 2010 Nov;35(10):1473-85. doi: 10.1016/j.psyneuen.2010.04.015. Epub 2010 May 26.

2.
3.

Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Onakomaiya MM, Porter DM, Oberlander JG, Henderson LP.

Horm Behav. 2014 Jul;66(2):283-97. doi: 10.1016/j.yhbeh.2014.04.008. Epub 2014 Apr 21.

4.

Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.

Oberlander JG, Henderson LP.

Neuropsychopharmacology. 2012 May;37(6):1483-99. doi: 10.1038/npp.2011.334. Epub 2012 Feb 1.

6.

Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.

Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.

Neuroscience. 2011 Jan 26;173:82-92. doi: 10.1016/j.neuroscience.2010.11.026. Epub 2010 Nov 18.

PMID:
21093544
7.

Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.

Sink KS, Walker DL, Freeman SM, Flandreau EI, Ressler KJ, Davis M.

Mol Psychiatry. 2013 Mar;18(3):308-19. doi: 10.1038/mp.2011.188. Epub 2012 Jan 31.

8.

Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala.

Choi SH, Kim SJ, Park SH, Moon BH, Do E, Chun BG, Lee MS, Shin KH.

Peptides. 2005 Nov;26(11):2246-51. Epub 2005 Apr 25.

PMID:
16269353
9.
10.

Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation.

Regev L, Neufeld-Cohen A, Tsoory M, Kuperman Y, Getselter D, Gil S, Chen A.

Mol Psychiatry. 2011 Jul;16(7):714-28. doi: 10.1038/mp.2010.64. Epub 2010 Jun 15.

PMID:
20548294
12.

Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.

Walker DL, Miles LA, Davis M.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1291-308. doi: 10.1016/j.pnpbp.2009.06.022. Epub 2009 Jul 10. Review.

13.

Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.

Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.

J Pharmacol Exp Ther. 2000 Aug;294(2):588-97.

15.
16.

The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.

Sutherland JE, Burian LC, Covault J, Conti LH.

Pharmacol Biochem Behav. 2010 Dec;97(2):227-38. doi: 10.1016/j.pbb.2010.08.003. Epub 2010 Aug 13.

18.

Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.

Gafford GM, Guo JD, Flandreau EI, Hazra R, Rainnie DG, Ressler KJ.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16330-5. doi: 10.1073/pnas.1119261109. Epub 2012 Sep 19.

19.

Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat.

Makino S, Shibasaki T, Yamauchi N, Nishioka T, Mimoto T, Wakabayashi I, Gold PW, Hashimoto K.

Brain Res. 1999 Dec 11;850(1-2):136-43.

PMID:
10629757
20.
Items per page

Supplemental Content

Write to the Help Desk